Who is sponsoring NCT03919058?

NCT03919058 is sponsored by Hasselt University.

What drugs are being tested in NCT03919058?

Interventions in NCT03919058: Baseline activity (control regime), Increased sitting time (sit regime), Non-exercise physical activity (sit less regime), Structured exercise (exercise regime).

What condition does NCT03919058 study?

NCT03919058 studies Multiple Sclerosis.

Is NCT03919058 still recruiting?

NCT03919058 is currently completed. Last updated 31 August 2021.

Last reviewed 2021-08-31 · How we verify

NCT03919058

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sit Less or Exercise More: Impact on Cardiometabolic Health in MS

Completed NA Last updated 31 August 2021

What this trial tests

NA trial testing Baseline activity (control regime) in Multiple Sclerosis in 28 participants. Completed in 30 April 2021.

Timeline

13 April 2019

Primary endpoint
30 April 2021

30 April 2021

Quick facts

Lead sponsor	Hasselt University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	prevention
Enrollment	28
Start date	13 April 2019
Primary completion	30 April 2021
Estimated completion	30 April 2021
Sites	1 location across Belgium

Drugs / interventions tested

Baseline activity (control regime)
Increased sitting time (sit regime)
Non-exercise physical activity (sit less regime)
Structured exercise (exercise regime)

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Hasselt University

Who can join

Adults 18 to 75, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the impact of reducing sitting time and increasing exercise time on cardiometabolic health in persons with Multiple Sclerosis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Replacing sitting with light-intensity physical activity throughout the day versus 1 bout of vigorous-intensity exercise: similar cardiometabolic health effects in multiple sclerosis. A randomised cross-over study.
Nieste I, Franssen WMA, Duvivier BMFM, Spaas J, et al · · 2023 · cited 7× · PMID 36190113 · DOI 10.1080/09638288.2022.2122601

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other Hasselt University trials

Trials by the same sponsor.

NCT07419100 — Sedentary Behaviour, Physical Activity Patterns, and Cardiometabolic Health · NA · not yet recruiting
NCT07505355 — Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis · recruiting
NCT07081893 — How do Patients, Relatives and Healthcare Professionals View Person-centered Rehabilitation. · not yet recruiting
NCT06785909 — Proprioceptive, Fear-related and Inflammatory Factors in the Persistence of Pregnancy-related Lumbopelvic Pain. · NA · recruiting
NCT07175792 — Accuracy of Motor Performance Perception in Multiple Sclerosis · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03919058 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hasselt University
Last refreshed: 31 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03919058.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing